Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Apoptosis	4/142	1.7706963311466067e-05	0.0005422214381956773	38.309178743961354	-100.74461672219032	CASP10;FAS;FASLG;XIAP
KEGG_2021_Human	Autoimmune thyroid disease	3/53	3.098408218261013e-05	0.0005422214381956773	68.72571428571429	-119.39488334977806	CTLA4;FAS;FASLG
KEGG_2021_Human	Hepatitis B	4/162	2.979383554686203e-05	0.0005422214381956773	33.37552742616034	-89.36652156273904	CASP10;FAS;FASLG;STAT3
KEGG_2021_Human	Necroptosis	4/159	2.7677777198301538e-05	0.0005422214381956773	34.034408602150535	-90.91492941118791	FAS;FASLG;STAT3;XIAP
KEGG_2021_Human	T cell receptor signaling pathway	3/104	0.0002329673917108638	0.0032615434839520932	33.806223479490804	-67.40758155759835	CD4;CD8A;CTLA4
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	3/131	0.0004602084037564585	0.005369098043825349	26.584821428571427	-54.62268457986884	FAS;FASLG;SH2D1A
KEGG_2021_Human	Measles	3/139	0.0005476317685268026	0.005476317685268025	24.99579831932773	-51.672386684351224	FAS;FASLG;STAT3
KEGG_2021_Human	African trypanosomiasis	2/37	0.0008976760152685225	0.0055237054736592545	57.378571428571426	-64.24352876962546	FAS;FASLG
KEGG_2021_Human	Allograft rejection	2/38	0.0009469209383415865	0.0055237054736592545	55.77777777777778	-62.87407127134141	FAS;FASLG
KEGG_2021_Human	Primary immunodeficiency	2/38	0.0009469209383415865	0.0055237054736592545	55.77777777777778	-62.87407127134141	CD4;CD8A
KEGG_2021_Human	Cell adhesion molecules	3/148	0.0006580280370873506	0.0055237054736592545	23.417733990147784	-48.687210890592894	CD4;CD8A;CTLA4
KEGG_2021_Human	Hepatitis C	3/157	0.0007818177127513567	0.0055237054736592545	22.024118738404454	-46.00245527612638	FAS;FASLG;STAT3
KEGG_2021_Human	Type I diabetes mellitus	2/43	0.0012123028259538784	0.006061514129769392	48.94512195121951	-56.84526782917664	FAS;FASLG
KEGG_2021_Human	Graft-versus-host disease	2/42	0.0011566808072543669	0.006061514129769392	50.175	-57.95352918467438	FAS;FASLG
KEGG_2021_Human	Proteoglycans in cancer	3/205	0.0016941022902244062	0.007905810687713895	16.68882602545969	-35.25303962280841	FAS;FASLG;STAT3
KEGG_2021_Human	Lipid and atherosclerosis	3/215	0.0019428303639941794	0.00799988973409368	15.881401617250674	-33.55383703082171	FAS;FASLG;STAT3
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.00799988973409368	16.115516062884485	-34.04865723073064	CD4;FAS;FASLG
KEGG_2021_Human	Human cytomegalovirus infection	3/225	0.00221350447353219	0.008608072952625183	15.146718146718147	-31.989452913184095	FAS;FASLG;STAT3
KEGG_2021_Human	Pathways in cancer	4/531	0.0028173482711087343	0.01037970415671639	9.539531941808981	-25.060320343159585	FAS;FASLG;STAT3;XIAP
KEGG_2021_Human	Antigen processing and presentation	2/78	0.003939415117888246	0.013787952912608861	26.289473684210527	-34.099339569929285	CD4;CD8A
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.015929861515504844	11.412915851272016	-23.74866982495136	CD4;FAS;FASLG
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.005099890907028776	0.01622692561327338	22.933908045977013	-30.23706529396038	CD4;STAT3
KEGG_2021_Human	Hematopoietic cell lineage	2/99	0.006275930773922806	0.019100658877156364	20.54381443298969	-27.37901341152302	CD4;CD8A
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.019398304691131785	19.92	-26.61700675496218	FAS;FASLG
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.02043465592802589	18.95952380952381	-25.42995427691617	CD4;STAT3
KEGG_2021_Human	Toxoplasmosis	2/112	0.007973056255711614	0.020670886588881963	18.086363636363636	-24.33571316400054	STAT3;XIAP
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.020670886588881963	18.086363636363636	-24.33571316400054	CASP10;FAS
KEGG_2021_Human	FoxO signaling pathway	2/131	0.010785539693571716	0.026963849233929287	15.385658914728682	-20.853034219946885	FASLG;STAT3
KEGG_2021_Human	Yersinia infection	2/137	0.011753397776716717	0.028370270495523108	14.690740740740742	-19.931093924152265	CD4;CD8A
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.03471866079220714	12.933006535947712	-17.54750234216727	FAS;FASLG
KEGG_2021_Human	Influenza A	2/172	0.01812904275363809	0.040936548153376336	11.614705882352942	-15.707848772731996	FAS;FASLG
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	2/193	0.02252556995474682	0.049274684276008666	10.31020942408377	-13.840129933766221	FAS;STAT3
KEGG_2021_Human	Pathogenic Escherichia coli infection	2/197	0.0234094024256627	0.04965630817564815	10.093589743589744	-13.525208778126117	FAS;FASLG
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.05051240264924934	9.835	-13.147442958027579	FAS;STAT3
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.057052881843807815	9.044930875576037	-11.980722307867735	CD4;XIAP
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.0652184605082735	8.26054852320675	-10.803362590978235	STAT3;XIAP
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.0926629529680274	6.657534246575342	-8.337786615237395	FAS;FASLG
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.11163953009547388	5.880699088145897	-7.115618067766183	FAS;FASLG
KEGG_2021_Human	Inflammatory bowel disease	1/65	0.07765521083230079	0.13506509810442055	13.895833333333334	-8.322075559905016	STAT3
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.13506509810442055	13.47138047138047	-8.082458738692866	STAT3
KEGG_2021_Human	p53 signaling pathway	1/73	0.0868275630671275	0.13506509810442055	12.339506172839506	-7.43259286356604	FAS
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.13506509810442055	13.071895424836601	-7.854937277937848	STAT3
KEGG_2021_Human	Non-small cell lung cancer	1/72	0.0856855265026792	0.13506509810442055	12.514866979655713	-7.534346814915346	STAT3
KEGG_2021_Human	RIG-I-like receptor signaling pathway	1/70	0.08339759626885078	0.13506509810442055	12.880837359098228	-7.74542097629872	CASP10
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.13506509810442055	12.880837359098228	-7.74542097629872	STAT3
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.13733082994047746	11.841481481481482	-7.141387005986298	STAT3
KEGG_2021_Human	Th1 and Th2 cell differentiation	1/92	0.10828375753966943	0.15628622413087245	9.739926739926739	-5.8737398650795125	CD4
KEGG_2021_Human	Small cell lung cancer	1/92	0.10828375753966943	0.15628622413087245	9.739926739926739	-5.8737398650795125	XIAP
KEGG_2021_Human	Rheumatoid arthritis	1/93	0.1094003568916107	0.15628622413087245	9.632850241545894	-5.8073541800756905	CTLA4
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.15899508243468125	4.014270613107822	-4.131104230952899	FAS;FASLG
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.16083719364912633	8.94388327721661	-5.375723879218761	STAT3
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.16175808827463806	8.189300411522634	-4.893732148578802	STAT3
KEGG_2021_Human	Herpes simplex virus 1 infection	2/498	0.12295964829332588	0.16175808827463806	3.816532258064516	-3.814605004177811	FAS;FASLG
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.16175808827463806	8.2668743509865	-4.943743954376122	STAT3
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.16175808827463806	8.592233009708737	-5.152341092635986	XIAP
KEGG_2021_Human	Neurotrophin signaling pathway	1/119	0.13799386385009413	0.1694661485878349	7.4858757062146895	-4.435243302362896	FASLG
KEGG_2021_Human	Growth hormone synthesis, secretion and action	1/119	0.13799386385009413	0.1694661485878349	7.4858757062146895	-4.435243302362896	STAT3
KEGG_2021_Human	Ubiquitin mediated proteolysis	1/140	0.16048249753809815	0.1936857728908081	6.338129496402877	-3.6670604531534	XIAP
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.19416301101736594	6.2018779342723	-3.57415842622014	STAT3
KEGG_2021_Human	JAK-STAT signaling pathway	1/162	0.18347437883820783	0.21405344197790915	5.456866804692892	-3.0596637281364782	STAT3
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.22905041591460032	4.896958410924891	-2.6658400097237527	CASP10
KEGG_2021_Human	NOD-like receptor signaling pathway	1/181	0.20287322552436027	0.22905041591460032	4.869135802469136	-2.6461154603833723	XIAP
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.2376817645277418	4.5823152995927865	-2.441961042053517	STAT3
KEGG_2021_Human	Focal adhesion	1/201	0.22284403856827387	0.24210968862869484	4.371111111111111	-2.2907190203417165	XIAP
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.24210968862869484	4.326732673267327	-2.2588473265567357	STAT3
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.26423427082769974	3.7696007696007694	-1.8563524399324505	STAT3
KEGG_2021_Human	Ras signaling pathway	1/232	0.25290994493508406	0.26423427082769974	3.7696007696007694	-1.8563524399324505	FASLG
KEGG_2021_Human	MicroRNAs in cancer	1/310	0.3239838755949599	0.33351281311245873	2.7900035958288387	-1.143955577607994	STAT3
KEGG_2021_Human	PI3K-Akt signaling pathway	1/354	0.36133488698431165	0.3665716244768379	2.4283915643689014	-0.883914601009246	FASLG
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.3736370340305108	2.32487922705314	-0.8103995559567543	FAS
